Creative Planning’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.75M Buy
372,055
+72,494
+24% +$1.12M ﹤0.01% 713
2025
Q1
$4.45M Buy
299,561
+48,219
+19% +$717K ﹤0.01% 754
2024
Q4
$3.33M Buy
251,342
+93,712
+59% +$1.24M ﹤0.01% 843
2024
Q3
$2.24M Buy
157,630
+49,871
+46% +$709K ﹤0.01% 1006
2024
Q2
$1.39M Sell
107,759
-37,369
-26% -$484K ﹤0.01% 1183
2024
Q1
$2.02M Buy
145,128
+39,012
+37% +$542K ﹤0.01% 951
2023
Q4
$1.51M Sell
106,116
-18,877
-15% -$269K ﹤0.01% 1034
2023
Q3
$1.93M Sell
124,993
-1,951
-2% -$30.2K ﹤0.01% 858
2023
Q2
$1.99M Buy
126,944
+27,768
+28% +$436K ﹤0.01% 815
2023
Q1
$1.63M Buy
99,176
+33,116
+50% +$546K ﹤0.01% 861
2022
Q4
$1.03M Sell
66,060
-1,280
-2% -$20K ﹤0.01% 1016
2022
Q3
$873K Buy
67,340
+25,057
+59% +$325K ﹤0.01% 1012
2022
Q2
$594K Buy
42,283
+5,779
+16% +$81.2K ﹤0.01% 1217
2022
Q1
$523K Buy
36,504
+5,283
+17% +$75.7K ﹤0.01% 1299
2021
Q4
$426K Sell
31,221
-4,071
-12% -$55.5K ﹤0.01% 1400
2021
Q3
$578K Buy
35,292
+2,893
+9% +$47.4K ﹤0.01% 1213
2021
Q2
$545K Sell
32,399
-11,366
-26% -$191K ﹤0.01% 1231
2021
Q1
$799K Buy
43,765
+8,806
+25% +$161K ﹤0.01% 1145
2020
Q4
$636K Sell
34,959
-18,425
-35% -$335K ﹤0.01% 1157
2020
Q3
$952K Buy
53,384
+8,347
+19% +$149K ﹤0.01% 818
2020
Q2
$808K Sell
45,037
-3,687
-8% -$66.1K ﹤0.01% 815
2020
Q1
$740K Sell
48,724
-180
-0.4% -$2.73K ﹤0.01% 762
2019
Q4
$965K Sell
48,904
-2,919
-6% -$57.6K ﹤0.01% 801
2019
Q3
$891K Buy
51,823
+314
+0.6% +$5.4K ﹤0.01% 807
2019
Q2
$912K Buy
51,509
+13,679
+36% +$242K ﹤0.01% 788
2019
Q1
$771K Buy
+37,830
New +$771K ﹤0.01% 832